12/4
07:10 am
rprx
Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
Low
Report
Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
12/3
06:18 pm
rprx
Royalty Pharma plc (RPRX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Medium
Report
Royalty Pharma plc (RPRX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
11/29
12:31 am
rprx
Royalty Pharma (NASDAQ:RPRX) was downgraded by analysts at
Wall Street Z
Low
Report
Royalty Pharma (NASDAQ:RPRX) was downgraded by analysts at
Wall Street Z
11/26
09:15 am
rprx
Royalty Pharma to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Royalty Pharma to Present at Upcoming Investor Conferences [Yahoo! Finance]
11/26
08:15 am
rprx
Royalty Pharma to Present at Upcoming Investor Conferences
Low
Report
Royalty Pharma to Present at Upcoming Investor Conferences
11/19
06:53 am
rprx
Royalty Pharma (NASDAQ:RPRX) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "hold" rating.
Medium
Report
Royalty Pharma (NASDAQ:RPRX) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "hold" rating.
11/18
04:36 pm
rprx
How Analyst Views on Royalty Pharma Are Shifting With Recent Acquisition and Growth Moves [Yahoo! Finance]
Medium
Report
How Analyst Views on Royalty Pharma Are Shifting With Recent Acquisition and Growth Moves [Yahoo! Finance]
11/17
07:42 am
rprx
3 Low-Volatility Stocks We Find Risky [Yahoo! Finance]
Low
Report
3 Low-Volatility Stocks We Find Risky [Yahoo! Finance]
11/15
07:13 am
rprx
Royalty Pharma: Guidance Raised Again, Platform Strength Intact -- Buy Reiterated [Seeking Alpha]
Neutral
Report
Royalty Pharma: Guidance Raised Again, Platform Strength Intact -- Buy Reiterated [Seeking Alpha]
11/12
07:13 am
rprx
Zenas BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Zenas BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/5
07:49 am
rprx
Royalty Pharma Reports Third Quarter 2025 Results [Yahoo! Finance]
Low
Report
Royalty Pharma Reports Third Quarter 2025 Results [Yahoo! Finance]
11/5
07:14 am
rprx
Royalty Pharma reports Q3 results [Seeking Alpha]
Low
Report
Royalty Pharma reports Q3 results [Seeking Alpha]
11/5
07:00 am
rprx
Royalty Pharma Reports Third Quarter 2025 Results
Medium
Report
Royalty Pharma Reports Third Quarter 2025 Results
11/4
07:15 am
rprx
Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences
Low
Report
Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences
10/17
08:15 am
rprx
Royalty Pharma Declares Fourth Quarter 2025 Dividend
Low
Report
Royalty Pharma Declares Fourth Quarter 2025 Dividend
10/10
10:07 am
rprx
Royalty Pharma (NASDAQ:RPRX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Royalty Pharma (NASDAQ:RPRX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
10/9
04:15 pm
rprx
Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025
Low
Report
Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025
10/2
07:20 am
rprx
Royalty Pharma (NASDAQ:RPRX) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
Low
Report
Royalty Pharma (NASDAQ:RPRX) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
9/30
07:03 am
rprx
Royalty Pharma (NASDAQ:RPRX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Low
Report
Royalty Pharma (NASDAQ:RPRX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
9/29
09:23 am
rprx
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director [Yahoo! Finance]
Low
Report
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director [Yahoo! Finance]
9/29
08:15 am
rprx
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
Low
Report
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
9/27
10:17 am
rprx
Assessing Royalty Pharma (RPRX): Is the Recent Outperformance Reflected in Its Current Valuation? [Yahoo! Finance]
Low
Report
Assessing Royalty Pharma (RPRX): Is the Recent Outperformance Reflected in Its Current Valuation? [Yahoo! Finance]
9/24
07:04 am
rprx
Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth [Yahoo! Finance]
Medium
Report
Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth [Yahoo! Finance]
9/19
04:41 pm
rprx
Royalty Pharma to Present at Bernstein's 2nd Annual Healthcare Forum [Yahoo! Finance]
Low
Report
Royalty Pharma to Present at Bernstein's 2nd Annual Healthcare Forum [Yahoo! Finance]
9/19
04:25 pm
rprx
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum
Low
Report
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum